\-\ Texto\\:\\ \ \(0\)\
\-\ cranial\\ nerves\\ intact\\.\ \(0\)\
\-\ normal\\ laboratory\\ evaluation\ \(0\)\
\-\ radiation\\ therapy\ \(165\)\
\-\ \\â\\€\\¢\\ multifocal\\ enhancing\\ masses\\ in\\ midbrain\\,\\ pons\\ and\\ medulla\\.\ \(0\)\
\-\ \\â\\€\\¢\\ homogeneous\\ enhancement\\ following\\ contrast\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ hydrocephalus\\.\ \(0\)\
\-\ anaplastic\\ astrocytoma\ \(4\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ sarcoidosis\ \(1\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ multi\\-centric\\ glioma\ \(0\)\
\-\ 44\\ year\\ old\\ man\\ presents\\ with\\ one\\ week\\ history\\ of\\ paresthesia\\,\\ ataxia\\ and\\ slurred\\ speech\\.\ \(1\)\
\-\ brainstem\\ gliomas\\ are\\ quite\\ unusual\\ in\\ adults\\.\ \(0\)\
\-\ most\\ such\\ lesions\\ are\\ not\\ anaplastic\\ and\\ typically\\ present\\ in\\ children\\.\\ \\ the\\ new\\ who\\ classification\\ \\(2007\\)\\ indicates\\ that\\ any\\ vascular\\ changes\\ upgrade\\ the\\ neoplasm\\ from\\ anaplastic\\ to\\ gbm\\.\\ \\ thus\\,\\ contrast\\ enhancement\\ should\\ be\\ viewed\\ as\\ a\\ very\\ ominous\\ finding\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ anaplastic\\:\\ 0\\.41081223863704486\ \(0\)\
\-\ upgrade\\:\\ 0\\.1995448293036216\ \(0\)\
\-\ ominous\\:\\ 0\\.1795020028903254\ \(0\)\
\-\ paresthesia\\:\\ 0\\.15860126760794235\ \(0\)\
\-\ viewed\\:\\ 0\\.15698023929231114\ \(0\)\
\-\ slurred\\:\\ 0\\.15547109803521314\ \(0\)\
\-\ medulla\\:\\ 0\\.14429736359869405\ \(0\)\
\-\ gliomas\\:\\ 0\\.14429736359869405\ \(0\)\
\-\ enhancement\\:\\ 0\\.1436383927531656\ \(0\)\
\-\ midbrain\\:\\ 0\\.13889757779028114\ \(0\)\
\-\ quite\\:\\ 0\\.13401656425532005\ \(0\)\
\-\ gbm\\:\\ 0\\.13193176155811182\ \(0\)\
\-\ indicates\\:\\ 0\\.13144019318010086\ \(0\)\
\-\ speech\\:\\ 0\\.12870239058065883\ \(0\)\
\-\ pons\\:\\ 0\\.1282776418512721\ \(0\)\
\-\ classification\\:\\ 0\\.1282776418512721\ \(0\)\
\-\ brainstem\\:\\ 0\\.12588903048898914\ \(0\)\
\-\ 2007\\:\\ 0\\.123396628316311\ \(0\)\
\-\ contrast\\:\\ 0\\.1212527329178583\ \(0\)\
\-\ multifocal\\:\\ 0\\.12115939383672686\ \(0\)\
\-\ ataxia\\:\\ 0\\.12115939383672686\ \(0\)\
\-\ nerves\\:\\ 0\\.11652278365166513\ \(0\)\
\-\ adults\\:\\ 0\\.11652278365166513\ \(0\)\
\-\ thus\\:\\ 0\\.11463999865539462\ \(0\)\
\-\ unusual\\:\\ 0\\.1118889351448156\ \(0\)\
\-\ 44\\:\\ 0\\.11035329615915868\ \(0\)\
\-\ homogeneous\\:\\ 0\\.11016870542446063\ \(0\)\
\-\ glioma\\:\\ 0\\.10599758095839175\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.10569586759215957\ \(0\)\
\-\ children\\:\\ 0\\.10223855039216918\ \(0\)\
\-\ cranial\\:\\ 0\\.10198420017454045\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.10185812563387686\ \(0\)\
\-\ are\\:\\ 0\\.09469403377143004\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.09419498552837932\ \(0\)\
\-\ in\\:\\ 0\\.093121050611763\ \(0\)\
\-\ laboratory\\:\\ 0\\.09060909380028234\ \(0\)\
\-\ intact\\:\\ 0\\.09031046974586246\ \(0\)\
\-\ very\\:\\ 0\\.08950967284721144\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0888756031687904\ \(0\)\
\-\ typically\\:\\ 0\\.08759448647217023\ \(0\)\
\-\ new\\:\\ 0\\.08632239130404641\ \(0\)\
\-\ neoplasm\\:\\ 0\\.08517879230958415\ \(0\)\
\-\ masses\\:\\ 0\\.08494546879330987\ \(0\)\
\-\ week\\:\\ 0\\.08392525876041282\ \(0\)\
\-\ radiation\\:\\ 0\\.0826872923568839\ \(0\)\
\-\ vascular\\:\\ 0\\.08237554543287592\ \(0\)\
\-\ finding\\:\\ 0\\.08201736876154245\ \(0\)\
\-\ should\\:\\ 0\\.0814166754827215\ \(0\)\
\-\ any\\:\\ 0\\.08064058087043431\ \(0\)\
\-\ such\\:\\ 0\\.08026262119043959\ \(0\)\
\-\ enhancing\\:\\ 0\\.0781650479145381\ \(0\)\
\-\ and\\:\\ 0\\.07735062451008758\ \(0\)\
\-\ evaluation\\:\\ 0\\.07609572566542856\ \(0\)\
\-\ changes\\:\\ 0\\.0754097292007066\ \(0\)\
\-\ following\\:\\ 0\\.07485405480831522\ \(0\)\
\-\ lymphoma\\:\\ 0\\.07431214751645299\ \(0\)\
\-\ therapy\\:\\ 0\\.07169220692121442\ \(0\)\
\-\ lesions\\:\\ 0\\.0716605744178702\ \(0\)\
\-\ one\\:\\ 0\\.0714404185612006\ \(0\)\
\-\ who\\:\\ 0\\.07058130614471186\ \(0\)\
\-\ metastatic\\:\\ 0\\.06843368276852987\ \(0\)\
\-\ man\\:\\ 0\\.06605824220409467\ \(0\)\
\-\ most\\:\\ 0\\.06493748264049923\ \(0\)\
\-\ present\\:\\ 0\\.06402688821338354\ \(0\)\
\-\ multiple\\:\\ 0\\.06103091459683821\ \(0\)\
\-\ presents\\:\\ 0\\.060023949803434534\ \(0\)\
\-\ that\\:\\ 0\\.054148333051652606\ \(0\)\
\-\ disease\\:\\ 0\\.05237675297347295\ \(0\)\
\-\ normal\\:\\ 0\\.050945418981736566\ \(0\)\
\-\ be\\:\\ 0\\.05061684838056247\ \(0\)\
\-\ as\\:\\ 0\\.05012715893600898\ \(0\)\
\-\ the\\:\\ 0\\.049794876421378226\ \(0\)\
\-\ from\\:\\ 0\\.04955594622667803\ \(0\)\
\-\ not\\:\\ 0\\.04925880441676547\ \(0\)\
\-\ history\\:\\ 0\\.04767185640756168\ \(0\)\
\-\ no\\:\\ 0\\.040575906518334925\ \(0\)\
\-\ year\\:\\ 0\\.038453668731283426\ \(0\)\
\-\ old\\:\\ 0\\.03692883304979854\ \(0\)\
\-\ to\\:\\ 0\\.03119388644841534\ \(0\)\
\-\ with\\:\\ 0\\.024432803764802044\ \(0\)\
\-\ of\\:\\ 0\\.024418213887822608\ \(0\)\
